Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib with or without gefitinib for recurrent or progressive glioblastoma
ISRCTN00549973Phase 2Completed
- Sponsor
- University College London
- Start
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in glioblastoma (GBM) comparing Cediranib + gefitinib with Cediranib + placebo (2 arms). Primary endpoint: Progression-free survival. Started May 2011; status: completed.
02
Drugs
cediranibgefitinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on ISRCTN00549973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN00549973.